Press Release

September 21, 2023 | Press Release
Nobias Therapeutics Announces Acceptance of Late-Breaking Abstract and Presentation of Phase 2 Clinical Data for NB-001 at 52nd Child Neurology Society Annual Meeting
September 19, 2023 | Press Release
AVILAR THERAPEUTICS TO PRESENT AT UPCOMING INDUSTRY CONFERENCES
August 24, 2023 | Press Release
Aspen Neuroscience to Partner with Rune Labs and Emerald Innovations to Incorporate both Active and Passive Digital Health Monitoring in Trial Ready Cohort Screening Study
August 08, 2023 | Press Release
Aspen Neuroscience Announces FDA Clearance of Investigational New Drug Application for ANPD001, Autologous Cell Therapy for the Treatment of Parkinson’s Disease
July 25, 2023 | Press Release
Truvian Health Presents Multi-Site Clinical Study Data on Its Benchtop Blood Testing Platform to Enable Central Laboratory Quality Results Anywhere
June 29, 2023 | Press Release
Dr. Andres Bratt-Leal to Present Preclinical Safety and Efficacy Data for ANPD001 at the 2023 World Parkinson Congress in Barcelona
June 27, 2023 | Press Release
SonoThera™ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
June 21, 2023 | Press Release
Dr. Andrés Bratt-Leal to Present at the 2023 International Society for Stem Cell Research Annual Meeting Focus Sessions
March 30, 2023 | Press Release
ProJenX Announces Formation of Scientific Advisory Board
February 16, 2023 | Press Release
AVILAR THERAPEUTICS INCREASES FINANCING TO $75 MILLION TO ADVANCE PIPELINE OF NOVEL EXTRACELLULAR PROTEIN DEGRADERS